Etomi Michael E MD is categorized under Physicians Offices in Charlotte, NC and active since 2008.
Etomi Michael E MD was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Etomi at the company’s single location by writing to 2711 Randolph Road # 400, Charlotte, North Carolina NC 28207 or by phoning (704) 348-2992. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Etomi Michael E MD |
| Contact Person: | Michael Etomi |
| Address: | 2711 Randolph Road # 400, Charlotte, North Carolina 28207 |
| Phone Number: | (704) 348-2992 |
| Website Address: | metrolinanephrology.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Etomi Michael E MD was started in 2008 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Etomi for inquiries that concern Etomi Michael E MD by calling the company number (704) 348-2992, as your correspondence is most welcome. Additionally, the physical location of the single location of Etomi Michael E MD can be found at the coordinates 35.20018,-80.81345 as well as the street address 2711 Randolph Road # 400 in Charlotte, North Carolina 28207.
For its online presence, you may visit Etomi Michael E MD’s website at metrolinanephrology.com and engage with its social media outlets through on Twitter and on Facebook.